Log in

SCS Stem Cells Spin SA GPW · Poland

Stem Cells Spin SA (SCS) news

Stem Cells Spin SA is a public biotech or pharmaceutical company listed on GPW under the ticker SCS, recorded under Poland. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Stem Cells Spin SA news

We have not published a story on Stem Cells Spin SA yet. When there is news, it will appear here.

Questions about Stem Cells Spin SA

What is the ticker symbol of Stem Cells Spin SA?

Stem Cells Spin SA trades under the ticker SCS on GPW.

Where is Stem Cells Spin SA listed?

Stem Cells Spin SA is listed on GPW.

Which country or territory is Stem Cells Spin SA listed under?

Our directory records Stem Cells Spin SA under Poland.

What does Stem Cells Spin SA do?

Our directory classifies Stem Cells Spin SA as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Stem Cells Spin SA?

The ISIN recorded for Stem Cells Spin SA is PLSTCLS00013.

Does aibio.space cover Stem Cells Spin SA?

aibio.space lists Stem Cells Spin SA among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Stem Cells Spin SA?

Companies in our directory listed in the same country and business area as Stem Cells Spin SA: SYNTHAVERSE Spolka Akcyjna, BIOTON, Syn2bio Spolka Akcyjna, Medicofarma Biotech Spolka Akcyjna, MedTech Solutions, Ryvu Therapeutics SA.

Investor discussion: Stem Cells Spin SA

Members talk about Stem Cells Spin SA (SCS). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open GPW:SCS on TradingView.

Listing details

Stem Cells Spin SA is a public biotech or pharmaceutical company listed on GPW under the ticker SCS, recorded under Poland. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Stem Cells Spin SA
Ticker
SCS
Listing
GPW
Country or territory
Poland
Business scope
Pharmaceuticals: Major
ISIN
PLSTCLS00013
Last quote in directory
2026-10-21
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.